Kiomars Karami is a notable inventor based in Aliso Viejo, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new crystalline forms of important compounds. With a total of 2 patents, his work has implications for the treatment of various ocular disorders.

Latest Patents

Karami's latest patents include a crystalline form of cyclosporine A, which relates to a newly identified form of this compound. The invention encompasses methods for its preparation and applications in treating certain ocular disorders. Another significant patent is for 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II. This new crystalline form is recognized as the most stable form of bimatoprost known to date and can be readily prepared from crystalline form I.

Career Highlights

Karami is currently employed at Allergan, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of crystalline forms of pharmaceutical compounds.

Collaborations

Throughout his career, Karami has collaborated with esteemed colleagues, including Ke Wu and Gyorgy F Ambrus. These collaborations have further enriched his research and development efforts.

Conclusion

Kiomars Karami's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also has practical applications in medicine.

Profile summary based on public USPTO records.